ArticleScientific reports2024
SHIVA-CMB: a deep-learning-based robust cerebral microbleed segmentation tool trained on multi-source T2*GRE- and susceptibility-weighted MRI.
Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Accuracy of Deep Learning in Detecting Cerebral Microbleeds: Systematic Review and Meta-Analysis.Journal of medical Internet research · 2026Pooled it
- A geometric-to-neural cascade for cerebral microbleed detection in susceptibility-weighted MRI.bioRxiv : the preprint server for biology · 2026Article
- Automated detection of cerebral microbleeds on ex-vivo MRI scans of community-based older adults.NeuroImage · 2026Article
- Interactions between blood pressure variability, cerebral autoregulation, and covert cerebral small vessel disease in relation to cognitive performance in community-dwelling older adults.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026Article
- Imaging research, diagnosis, and treatment advances of post-stroke cognitive impairment.Frontiers in neuroimaging · 2026Review
- Attention-enhanced segmentation network for automated cerebral microbleed detection and burden assessment.Frontiers in neuroscience · 2026Article
- Deep learning-based detection of cerebral microbleeds on 2D T2*-weighted GRE MRI: toward ARIA-H risk assessment in Alzheimer's treatment.Frontiers in aging neuroscience · 2026Article
- Cognitive implications and associated transcriptomic signatures of distinct regional iron depositions in cerebral small vessel disease.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025Article
- Application of susceptibility-weighted imaging in staging diagnosis of ischemic cerebral infarction and its prognostic value.Frontiers in neurologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cerebral microbleeds (CMB) represent a feature of cerebral small vessel disease (cSVD), a prominent vascular contributor to age-related cognitive decline, dementia, and stroke. They are visible as spherical hypointense signals on T2*- or susceptibility-weighted magnetic resonance imaging (MRI) sequences. An increasing number of automated CMB detection methods being proposed are based on supervised deep learning (DL). Yet, the lack of open sharing of pre-trained models hampers the practical application and evaluation of these methods beyond specific data sources used in each study. Here, we present the SHIVA-CMB detector, a 3D Unet-based tool trained on 450 scans taken from seven acquisitions in six different cohort studies that included both T2*- and susceptibility-weighted MRI. In a held-out test set of 96 scans, it achieved the sensitivity, precision, and F1 (or Dice similarity coefficient) score of 0.67, 0.82, and 0.74, with less than one false positive detection per image (FPavg = 0.6) and per CMB (FPcmb = 0.15). It achieved a similar level of performance in a separate, evaluation-only dataset with acquisitions never seen during the training (0.67, 0.91, 0.77, 0.5, 0.07 for the sensitivity, precision, F1 score, FPavg, and FPcmb). Further demonstrating its generalizability, it showed a high correlation (Pearson's R = 0.89, p < 0.0001) with a visual count by expert raters in another independent set of 1992 T2*-weighted scans from a large, multi-center cohort study. Importantly, we publicly share both the pipeline ( https://github.com/pboutinaud/SHiVAi/ ) and pre-trained models ( https://github.com/pboutinaud/SHIVA-CMB/ ) to the research community to promote the active application and evaluation of our tool. We believe this effort will help accelerate research on the pathophysiology and functional consequences of CMB by enabling rapid characterization of CMB in large-scale studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.